Stock Ratings | Oppenheimer initiated coverage of Palisade Bio (PALI) with an "Outperform" rating and an $8 price target, indicating a potential upside of 296.04%; Morgan Stanley raised its price target for Apple (AAPL) to $364.
ServiceNow, Inc. NOW | 0.00 | |
NovoCure Ltd. NVCR | 0.00 | |
Palisade Bio PALI | 0.00 | |
Booz Allen Hamilton Holding Corporation Class A BAH | 0.00 | |
Denali Therapeutics Inc. DNLI | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Bernstein: Maintaining its "outperform" rating for ServiceNow ( ServiceNow, Inc.(NOW.US) stock, while raising its price target from $236 to $248.
HC Wainwright & Co.: Maintaining a "buy" rating on NovoCure ( NovoCure Ltd.(NVCR.US) ), while raising the price target from $46 to $52.
Evercore ISI Group: Maintaining its "Outperform Market" rating for ServiceNow ( ServiceNow, Inc.(NOW.US) ) stock, while raising its price target from $150 to $160.
Oppenheimer: Initial rating for Palisade Bio ( Palisade Bio(PALI.US) ) at "Outperforms Market", with a price target of $8.
Cantor Fitzgerald: Maintaining an "overweight" rating on Booz Allen Booz Allen Hamilton Holding Corporation Class A(BAH.US) , while lowering the price target from $160 to $140.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| ServiceNow, Inc.(NOW.US) | to lift | $248.0 | $91.94 | 169.74% | Bernstein |
| NovoCure Ltd.(NVCR.US) | to lift | $52.0 | $19.99 | 160.13% | HC Wainwright & Co. |
| ServiceNow, Inc.(NOW.US) | to lift | $160.0 | $91.94 | 74.03% | Evercore ISI Group |
| ServiceNow, Inc.(NOW.US) | to lift | $150.0 | $91.94 | 63.15% | JP Morgan |
| Denali Therapeutics Inc.(DNLI.US) | to lift | $36.0 | $23.42 | 53.71% | Morgan Stanley |
| Palisade Bio(PALI.US) | Initial classification | $8.0 | $2.02 | 296.04% | Oppenheimer |
| Booz Allen Hamilton Holding Corporation Class A(BAH.US) | cut | $140.0 | $65.87 | 112.54% | Cantor Fitzgerald |
| ADTRAN Holdings, Inc.(ADTN.US) | cut | $21.0 | $10.15 | 106.9% | B. Riley Securities |
| Sportradar Group AG Class A(SRAD.US) | cut | $28.0 | $14.28 | 96.08% | Guggenheim |
| Sandisk Corporation(SNDK.US) | cut | $3050.0 | $1610.33 | 89.4% | Susquehanna |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Morgan Stanley: Maintaining an "overweight" rating on Apple Apple Inc.(AAPL.US) ) stock, while raising the price target from $360 to $364.
Morgan Stanley: Maintaining an "overweight" rating on GE Vernova ( GE Vernova Inc.(GEV.US) ), while raising the price target from $1250 to $1350.
JP Morgan: Maintaining an "overweight" rating on GE Vernova ( GE Vernova Inc.(GEV.US) ), while raising the price target from $1302 to $1330.
Barclays: Maintaining an "overweight" rating on Google-A ( Alphabet Inc. Class A(GOOGL.US) ) stock, while raising its price target from $405 to $425.
JP Morgan: Maintaining an "overweight" rating on ServiceNow ServiceNow, Inc.(NOW.US) ) stock, while raising the price target from $145 to $150.
First Coverage
Morgan Stanley: Initial rating for Applied Digital ( Applied Digital(APLD.US) ) at "Market-like weight", with a price target of $36.5.
Morgan Stanley: Initial rating for HUT 8 ( HUT 8(HUT.US) ) stock at "overweight", with a price target of $263.
Keybanc: Initial rating for Vertiv Holdings ( VERTIV HOLDINGS LLC(VRT.US) ) stock at "overweight", with a price target of $360.
reduction
Citigroup: Maintaining a "buy" rating on Coinbase Global Coinbase(COIN.US) ) stock, while lowering its price target from $400 to $235.
JP Morgan: Maintaining an "overweight" rating on Google-C ( Alphabet Inc. Class C(GOOG.US) ) stock, while lowering the price target from $460 to $420.
Morgan Stanley: Maintaining a "market-matched weight" rating for IBM IBM Corp(IBM.US) ) stock, while lowering the price target from $293 to $190.
UBS: Maintaining a "neutral" rating on Tesla Tesla Motors, Inc.(TSLA.US) ) stock, while lowering its price target from $442 to $385.
Morgan Stanley: Maintaining a "market-matched weight" rating for Tesla ( Tesla Motors, Inc.(TSLA.US) ) stock, while lowering the price target from $417 to $400.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.